Prof. Dr. Sudip Das has over twenty-five years of teaching experience in the professional pharmacy and graduate programs in the USA and Canada. He is a full professor of Pharmaceutical Sciences at Butler University. He has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the revitalization of the graduate program and research infrastructure in pharmaceutical sciences at Butler University. His current research involves nanomedicine, targeted delivery of mRNA/siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases. Dr. Das has over 150 research publications, review articles, patents, proceedings, conference presentations, and book chapters, is a recipient of multiple awards/honors, and has secured extramural research funding from NIH, PDA, and the pharmaceutical industry.
Research areas: Nanomedicine, non-viral gene therapy, targeted delivery of anticancer drugs, modulation of MDR in cancer, formulation development of poorly soluble drugs and stability studies of pharmaceuticals.